US Stock MarketDetailed Quotes

IGC Pharma (IGC)

Watchlist
  • 0.3011
  • +0.0205+7.31%
Close Jan 22 15:59 ET
28.62MMarket Cap-4.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IGC Pharma (IGC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Total revenue
-53.64%191K
20.59%328K
-5.50%1.27M
11.86%330K
25.98%257K
41.58%412K
-50.99%272K
47.64%1.35M
77.71%295K
-38.55%204K
Operating revenue
-53.64%191K
20.59%328K
7.62%1.27M
151.91%330K
25.98%257K
41.58%412K
-50.99%272K
29.64%1.18M
-21.08%131K
-38.55%204K
Cost of revenue
-57.01%92K
59.63%174K
6.54%652K
41.94%176K
115.49%153K
82.91%214K
-63.67%109K
30.49%612K
20.39%124K
-69.13%71K
Gross profit
-50.00%99K
-5.52%154K
-15.55%619K
-9.94%154K
-21.80%104K
13.79%198K
-36.08%163K
65.84%733K
171.43%171K
30.39%133K
Operating expense
53.12%3M
-19.54%2.06M
-23.42%8.07M
-33.11%1.57M
-36.70%1.98M
-26.53%1.96M
6.89%2.56M
-12.34%10.53M
-42.93%2.34M
31.55%3.13M
Selling and administrative expenses
35.45%1.41M
-27.66%1.21M
-34.74%4.41M
-61.71%569K
-49.28%1.13M
-25.48%1.04M
1.40%1.67M
-20.98%6.76M
-58.83%1.49M
41.55%2.23M
Research and development costs
73.17%1.59M
-4.27%851K
-3.13%3.66M
16.61%997K
-5.65%852K
-27.68%917K
19.01%889K
9.01%3.77M
73.43%855K
12.03%903K
Operating profit
-64.72%-2.9M
20.49%-1.91M
24.00%-7.45M
34.93%-1.41M
37.36%-1.88M
29.35%-1.76M
-12.01%-2.4M
15.32%-9.8M
46.27%-2.17M
-31.61%-3M
Net non-operating interest income expense
Other net income (expense)
2,406.98%1.08M
1,600.00%306K
110.15%325K
130.07%215K
101.89%49K
7.50%43K
-71.88%18K
-5,026.15%-3.2M
-8,044.44%-715K
-9,034.48%-2.59M
Special income (charges)
----
----
--0
--0
--0
----
----
---3.35M
---722K
---2.62M
-Less:Impairment of capital assets
----
----
--0
--0
--0
----
----
--3.35M
--722K
--2.62M
Other non- operating income (expenses)
2,406.98%1.08M
1,600.00%306K
127.27%325K
2,971.43%215K
53.13%49K
7.50%43K
-71.88%18K
120.00%143K
-22.22%7K
10.34%32K
Income before tax
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
58.51%-1.2M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
58.51%-1.2M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Net income continuous Operations
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
58.51%-1.2M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Minority interest income
Net income attributable to the parent company
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
58.51%-1.2M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
58.51%-1.2M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Basic earnings per share
0.00%-0.02
33.33%-0.02
59.09%-0.09
75.00%-0.01
77.78%-0.02
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
Diluted earnings per share
0.00%-0.02
33.33%-0.02
59.09%-0.09
75.00%-0.01
77.78%-0.02
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Total revenue -53.64%191K20.59%328K-5.50%1.27M11.86%330K25.98%257K41.58%412K-50.99%272K47.64%1.35M77.71%295K-38.55%204K
Operating revenue -53.64%191K20.59%328K7.62%1.27M151.91%330K25.98%257K41.58%412K-50.99%272K29.64%1.18M-21.08%131K-38.55%204K
Cost of revenue -57.01%92K59.63%174K6.54%652K41.94%176K115.49%153K82.91%214K-63.67%109K30.49%612K20.39%124K-69.13%71K
Gross profit -50.00%99K-5.52%154K-15.55%619K-9.94%154K-21.80%104K13.79%198K-36.08%163K65.84%733K171.43%171K30.39%133K
Operating expense 53.12%3M-19.54%2.06M-23.42%8.07M-33.11%1.57M-36.70%1.98M-26.53%1.96M6.89%2.56M-12.34%10.53M-42.93%2.34M31.55%3.13M
Selling and administrative expenses 35.45%1.41M-27.66%1.21M-34.74%4.41M-61.71%569K-49.28%1.13M-25.48%1.04M1.40%1.67M-20.98%6.76M-58.83%1.49M41.55%2.23M
Research and development costs 73.17%1.59M-4.27%851K-3.13%3.66M16.61%997K-5.65%852K-27.68%917K19.01%889K9.01%3.77M73.43%855K12.03%903K
Operating profit -64.72%-2.9M20.49%-1.91M24.00%-7.45M34.93%-1.41M37.36%-1.88M29.35%-1.76M-12.01%-2.4M15.32%-9.8M46.27%-2.17M-31.61%-3M
Net non-operating interest income expense
Other net income (expense) 2,406.98%1.08M1,600.00%306K110.15%325K130.07%215K101.89%49K7.50%43K-71.88%18K-5,026.15%-3.2M-8,044.44%-715K-9,034.48%-2.59M
Special income (charges) ----------0--0--0-----------3.35M---722K---2.62M
-Less:Impairment of capital assets ----------0--0--0----------3.35M--722K--2.62M
Other non- operating income (expenses) 2,406.98%1.08M1,600.00%306K127.27%325K2,971.43%215K53.13%49K7.50%43K-71.88%18K120.00%143K-22.22%7K10.34%32K
Income before tax -6.06%-1.82M32.76%-1.6M45.22%-7.12M58.51%-1.2M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Income tax 0000000000
Net income -6.06%-1.82M32.76%-1.6M45.22%-7.12M58.51%-1.2M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Net income continuous Operations -6.06%-1.82M32.76%-1.6M45.22%-7.12M58.51%-1.2M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Minority interest income
Net income attributable to the parent company -6.06%-1.82M32.76%-1.6M45.22%-7.12M58.51%-1.2M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.06%-1.82M32.76%-1.6M45.22%-7.12M58.51%-1.2M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Basic earnings per share 0.00%-0.0233.33%-0.0259.09%-0.0975.00%-0.0177.78%-0.0260.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.09
Diluted earnings per share 0.00%-0.0233.33%-0.0259.09%-0.0975.00%-0.0177.78%-0.0260.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -